Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:(%22Lung cancer%22)

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 120494

  • Page / 4820
Export

Selection :

  • and

18F-FDG uptake predicts diagnostic yield of transbronchial biopsy in peripheral lung cancerUMEDA, Yukihiro; DEMURA, Yoshiki; AMESHIMA, Shingo et al.Lung cancer. 2014, Vol 85, Num 1, pp 47-52, issn 0169-5002, 6 p.Article

A decrease in the size of ground glass nodules may indicate the optimal timing for curative surgeryKANEDA, Hiroyuki; NAKANO, Takahito; TANIGUCHI, Yohei et al.Lung cancer. 2014, Vol 85, Num 2, pp 213-217, issn 0169-5002, 5 p.Article

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptideKOTSAKIS, Athanasios; PAPADIMITRAKI, Elisavet; KYRIAKI VETSIKA, Eleni et al.Lung cancer. 2014, Vol 86, Num 1, pp 59-66, issn 0169-5002, 8 p.Article

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621MOLINA, Julian R; FOSTER, Nathan R; REUNGWETWATTANA, Thanyanan et al.Lung cancer. 2014, Vol 85, Num 2, pp 245-250, issn 0169-5002, 6 p.Article

A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer)KENMOTSU, Hirotsugu; NIHO, Seiji; OSHITA, Fumihiro et al.Lung cancer. 2014, Vol 84, Num 3, pp 254-258, issn 0169-5002, 5 p.Article

A population-based review of the feasibility of platinum-based combination chemotherapy after tyrosine kinase inhibition in EGFR mutation positive non-small cell lung cancer patients with advanced diseaseMARIANO, Caroline; BOSDET, Ian; KARSAN, Aly et al.Lung cancer. 2014, Vol 83, Num 1, pp 73-77, issn 0169-5002, 5 p.Article

A systematic review and meta-analysis of surgical treatments for malignant pleural mesotheliomaCAO, Christopher; TIAN, David; PARK, John et al.Lung cancer. 2014, Vol 83, Num 2, pp 240-245, issn 0169-5002, 6 p.Article

Activation of AMP-activated protein kinase sensitizes lung cancer cells and H1299 xenografts to erlotinibHÜLSMANN, Helen J; ROLFF, Jana; SÜLTMANN, Holger et al.Lung cancer. 2014, Vol 86, Num 2, pp 151-157, issn 0169-5002, 7 p.Article

Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosisLIN, Chou-Han; LIN, Ming-Tzer; KUO, Yao-Wen et al.Lung cancer. 2014, Vol 85, Num 3, pp 479-480, issn 0169-5002, 2 p.Article

Alterations of LKB1 and KRAS and risk of brain metastasis: Comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinomaNI ZHAO; WILKERSON, Matthew D; HAITHCOCK, Benjamin E et al.Lung cancer. 2014, Vol 86, Num 2, pp 255-261, issn 0169-5002, 7 p.Article

Analysis of IncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypesJINGCHENG YANG; JINYUAN LIN; TIANXIAO LIU et al.Lung cancer. 2014, Vol 85, Num 2, pp 110-115, issn 0169-5002, 6 p.Article

Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinomaSUN, Jong-Mu; LIRA, Maruja; PANDYA, Kinnari et al.Lung cancer. 2014, Vol 83, Num 2, pp 259-264, issn 0169-5002, 6 p.Article

Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC)LUCAS, John T; KUREMSKY, Jeffrey G; SOIKE, Mike et al.Lung cancer. 2014, Vol 85, Num 1, pp 59-65, issn 0169-5002, 7 p.Article

Computed tomography attenuation predicts the growth of pure ground-glass nodulesEGUCHI, Takashi; KONDO, Ryoichi; SAKAIZAWA, Takao et al.Lung cancer. 2014, Vol 84, Num 3, pp 242-247, issn 0169-5002, 6 p.Article

Concomitant EGFR mutation and ALK rearrangement in lung adenocarcinoma is more frequent than expected: Report of a case and review of the literature with demonstration of genes alteration into the same tumor cellsBALDI, Licia; MENGOLI, Maria Cecilia; BISAGNI, Alessandra et al.Lung cancer. 2014, Vol 86, Num 2, pp 291-295, issn 0169-5002, 5 p.Article

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancerKIM, Eric S; XIMING TANG; SIDDIK, Zahid H et al.Lung cancer. 2014, Vol 85, Num 1, pp 88-93, issn 0169-5002, 6 p.Article

EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinibLARSEN, Anne Winther; NISSEN, Peter Henrik; MELDGAARD, Peter et al.Lung cancer. 2014, Vol 85, Num 3, pp 435-441, issn 0169-5002, 7 p.Article

EGFR mutated non-small cell lung cancer patients: More prone to development of bone and brain metastases?HENDRIKS, L. E. L; SMIT, E. F; GRÜNBERG, K et al.Lung cancer. 2014, Vol 84, Num 1, pp 86-91, issn 0169-5002, 6 p.Article

EGFR mutation frequency and effectiveness of erlotinib: A prospective observational study in Danish patients with non-small cell lung cancerWEBER, Britta; HAGER, Henrik; SORENSEN, Boe S et al.Lung cancer. 2014, Vol 83, Num 2, pp 224-230, issn 0169-5002, 7 p.Article

Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer modelMURAKAMI, Toshi; TAKIGAWA, Nagio; KIURA, Katsuyuki et al.Lung cancer. 2014, Vol 83, Num 1, pp 30-36, issn 0169-5002, 7 p.Article

Endobronchial metastasis: An epidemiologic and clinicopathologic study of 174 consecutive casesMARCHIONI, Alessandro; LASAGNI, Anna; BUSCA, Annalisa et al.Lung cancer. 2014, Vol 84, Num 3, pp 222-228, issn 0169-5002, 7 p.Article

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)YANG, James Chih-Hsin; WU, Yi-Long; CHAN, Valorie et al.Lung cancer. 2014, Vol 83, Num 2, pp 174-181, issn 0169-5002, 8 p.Article

Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancerPATEL, Suchit H; YAN MA; WERNICKE, A. Gabriella et al.Lung cancer. 2014, Vol 84, Num 2, pp 156-160, issn 0169-5002, 5 p.Article

Exposure-specific lung cancer risks in Chinese chrysotile textile workers and mining workersXIAORONG WANG; SIHAO LIN; EIJI YANO et al.Lung cancer. 2014, Vol 85, Num 2, pp 119-124, issn 0169-5002, 6 p.Article

High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancerPREUSSER, Matthias; BERGHOFF, Anna S; STREUBEL, Berthold et al.Lung cancer. 2014, Vol 83, Num 1, pp 83-89, issn 0169-5002, 7 p.Article

  • Page / 4820